אינטגרילין 2 מגמל

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

EPTIFIBATIDE

Mevcut itibaren:

MERCK SHARP & DOHME (ISRAEL - 1996) COMPANY LTD, ISRAEL

ATC kodu:

B01AC16

Farmasötik formu:

תמיסה להזרקה

Kompozisyon:

EPTIFIBATIDE 2 MG/ML

Uygulama yolu:

תוך-ורידי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

SCHERING-PLOUGH LABO. N.V , BELGIUM

Terapötik grubu:

EPTIFIBATIDE

Terapötik alanı:

EPTIFIBATIDE

Terapötik endikasyonlar:

Integrilin is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-Q-wave myocardial infarction. Integrilin is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. Integrilin is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (PTCA) balloon angioplasty, directional atheretomy, transluminal extraction catheter atherectomy, rotational ablation angioplasty, or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death, myorardial infarction, need for urgent intervention). Integrilin is intended for use with aspirin and heparin.

Yetkilendirme tarihi:

2013-10-31